Nonclassic Chest Discomfort in Urgent Care

Learning objectives#

• Recognize symptom descriptions that may represent myocardial ischemia even when the patient does not use the phrase chest pain.
• Separate the decision to transfer from the later decision to confirm or exclude myocardial infarction.
• Interpret an ECG and serial high-sensitivity cardiac troponin results as parts of one time-dependent pathway.
• Keep dangerous cardiovascular and noncardiovascular alternatives proportionate in the differential.
• Build communication, transfer, and follow-up plans that reduce delay and diagnostic bias.

Initial presentation#

A 61-year-old woman walks into an urgent care clinic late in the afternoon because of a burning pressure beneath the lower sternum and high in the upper abdomen, and it began while she was carrying groceries up one flight of stairs. She stopped, and the discomfort eased after about eight minutes. Two hours later it returned while she was sitting, this time with nausea, sweating, and an ache in the left shoulder, and she calls it bad indigestion and asks whether she can take an antacid and go home.

Her history includes hypertension and a long period of cigarette use that ended three years ago. She takes a blood-pressure medicine but is unsure of its name. She has no known coronary disease. Her mother had a myocardial infarction in her early sixties. The patient prefers to discuss complex information in Spanish, although she can answer basic questions in English.

At triage she is alert. Blood pressure is 154/88 mm Hg, pulse 92 per minute, and respiratory rate 18 per minute. Oxygen saturation is 97 percent on room air, and temperature is normal. The discomfort is now a 3 out of 10. She is not visibly breathless. A brief examination finds clear lungs, regular heart sounds without a new murmur, and a soft abdomen. It finds equal radial pulses and no unilateral leg swelling. Pressing on the chest wall produces mild tenderness but does not reproduce the burning pressure.

The clinic can obtain an ECG, but it cannot run a high-sensitivity cardiac troponin assay or observe serial results.

Problem representation#

This is an adult with cardiovascular risk factors and new exertional then resting central and upper-abdominal pressure accompanied by nausea, sweating, and shoulder discomfort. She is currently stable, but the symptom pattern has progressed over hours; a normal oxygen saturation and a mostly reassuring examination do not lower the risk enough for an antacid trial at home. The immediate problem is possible acute coronary syndrome in a site that cannot complete a validated rule-out pathway. That representation deliberately carries what changes disposition: progression from exertion to rest, associated autonomic symptoms, risk context, and the clinic's testing limits. Mild chest-wall tenderness is recorded, but it is not allowed to erase the rest of the pattern.

Prioritized differential#

1. Acute coronary syndrome#

Reasoning for: The discomfort began with exertion, recurred at rest, and came with nausea and sweating. Upper-abdominal burning and shoulder discomfort can function as anginal equivalents. Hypertension, prior tobacco use, and family history raise the prior probability.

Reasoning against or still uncertain: She is hemodynamically stable and has no known coronary disease. Those facts matter for immediate stability, but neither excludes myocardial ischemia. The diagnosis still requires ECG interpretation, serial cardiac troponin testing, and the clinical course.

2. Gastroesophageal or other upper gastrointestinal pain#

Reasoning for: Burning beneath the sternum and in the upper abdomen can arise from reflux, esophageal spasm, gastritis, or peptic disease.

Reasoning against or still uncertain: Exertional onset, recurrence at rest, and sweating make a purely gastrointestinal explanation less secure. So do nausea and shoulder discomfort. Improvement after an antacid, if it occurred, would not by itself exclude ischemia.

3. Acute aortic syndrome#

Why it cannot be missed: Aortic dissection can be rapidly fatal, and antithrombotic treatment may be harmful if this is the true diagnosis.

Case evidence: There is no abrupt maximal pain, tearing back pain, or pulse deficit. There is no new focal neurologic finding, hypotension, or new aortic-regurgitation murmur. These absences lower concern but do not create certainty. Any new feature in this cluster would redirect the pathway toward urgent aortic imaging and specialist care.

4. Pulmonary embolism#

Why it cannot be missed: Pulmonary embolism can present with chest discomfort, dyspnea, presyncope, or unexplained tachycardia.

Case evidence: She has no pleuritic quality, hypoxemia, or unilateral leg finding. She has no recent immobilization, prior venous thromboembolism, or current hormone use. The present pattern is more suggestive of myocardial ischemia. Pulmonary embolism testing should follow a validated pretest-probability approach if new history or findings raise suspicion, not a reflex scan.

5. Pneumothorax, pericarditis, myocarditis, or an acute abdominal process#

Clear bilateral breath sounds and the absence of sudden pleuritic pain make pneumothorax less likely. The discomfort is not positional, and there is no viral syndrome or typical diffuse ECG pattern yet to suggest pericarditis or myocarditis, and a soft abdomen without focal tenderness reduces concern for an acute abdominal catastrophe. These diagnoses remain conditional alternatives because the examination and ECG may evolve.

6. Musculoskeletal chest-wall pain#

Mild tenderness supports a possible musculoskeletal contributor. It does not reproduce the patient's main symptom and does not explain the exertional and autonomic pattern. Two processes can coexist, so one tender area should not close the case.

Focused history and examination#

The next questions are chosen because each can change risk, testing, or destination.

• Timing and trajectory: Ask for exact onset, duration, whether discomfort was maximal at onset, what she was doing, whether it recurred, and whether the threshold for symptoms is falling. A crescendo pattern supports urgent ischemia evaluation; abrupt maximal pain raises aortic concern.
• Symptom map: Ask about pressure, tightness, heaviness, burning, upper-abdominal discomfort, breathlessness, unusual fatigue, nausea, sweating, and pain in the arm, shoulder, back, neck, or jaw. The vocabulary should not be restricted to pain.
• Provocation and relief: Clarify exertion, meals, position, breathing, palpation, and rest. No single answer is decisive. Reproducibility and antacid response can mislead when used as binary tests.
• Vascular risk and prior testing: Document diabetes, hypertension, kidney disease, lipid history, tobacco use, prior coronary or vascular disease, pregnancy-related vascular history, early family disease, and prior ECG or imaging results.
• Alternative emergencies: Ask about tearing back pain, fainting, focal weakness, severe breathlessness, coughing blood, unilateral leg symptoms, recent surgery or immobility, stimulant use, fever, vomiting, and gastrointestinal bleeding.
• Treatment hazards: Confirm allergies, bleeding history, anticoagulants, recent procedures, possible pregnancy, kidney or liver disease, and every prescription, over-the-counter product, and supplement.

The focused examination repeats vital signs and assesses appearance, perfusion, and mental status. It assesses heart and lung findings, pulses in both arms, and a focused neurologic screen. It also assesses abdomen and legs. New hypotension, hypoxemia, or pulmonary edema would change urgency and the diagnostic branch. So would a new murmur, pulse asymmetry, or a focal neurologic deficit. A reassuring examination cannot complete an acute coronary syndrome rule-out.

Diagnostic strategy#

At urgent care#

The clinic obtains a 12-lead ECG promptly while arranging emergency medical transport. The tracing shows sinus rhythm, no ST elevation, and subtle horizontal ST-segment depression in the lateral leads. There is no prior tracing for comparison. Because the site cannot perform serial high-sensitivity troponin testing or monitored observation, a normal or nondiagnostic ECG would not have made discharge safe. What you can measure sets what you can exclude. The new depression increases concern and makes transfer more urgent.

Emergency transport is safer than private travel because symptoms can worsen en route and the receiving system can prepare. The handoff includes onset times, symptom progression, and risk factors. It includes vital signs, ECG findings, and medicines and allergies. It also includes language preference and treatments already given. A copy of the ECG travels with the patient.

At emergency care#

The emergency team repeats the ECG and uses its validated high-sensitivity cardiac troponin clinical decision pathway. The pathway must match the exact assay and local timing protocol. An older, less sensitive troponin assay cannot simply be substituted into a rapid pathway designed for a high-sensitivity assay.

Useful initial studies include:

• serial ECGs if symptoms continue or suspicion remains high;
• high-sensitivity cardiac troponin at the pathway-defined times;
• complete blood count to identify anemia or bleeding context;
• electrolytes and kidney function to guide testing and treatment safety;
• glucose, with other studies targeted to the presentation;
• chest imaging when pulmonary, aortic, or other thoracic disease remains plausible.

Tests are connected to decisions. A broad computed-tomography survey is not a substitute for a differential. Stress testing or coronary computed-tomography angiography belongs later, if the patient is in an appropriate intermediate-risk branch after myocardial infarction is not established. A single conventional troponin ordered too early is not a rule-out strategy.

Progressive results and interpretation#

The repeat ECG in the emergency department again shows lateral ST depression without ST elevation. Her discomfort resolves, but symptom resolution does not close the episode.

The first high-sensitivity troponin value is below that assay's 99th-percentile upper reference limit. Two hours later, the value is above the reference limit and has risen substantially. Exact numerical deltas are assay-specific, so the team applies the local validated pathway rather than a universal cutoff copied from another laboratory, or from a review article you happen to remember.

The rise and fall of cardiac troponin establishes acute myocardial injury. In this presentation, the ischemic symptom pattern and ischemic ECG change support acute myocardial infarction rather than a nonischemic injury alone. The working diagnosis becomes a non-ST-elevation acute coronary syndrome. Cardiology evaluates the patient through the current acute coronary syndrome pathway.

This sequence illustrates why the first result was not falsely negative. It was a time-limited measurement obtained before the biomarker had risen above the reference boundary. The information became diagnostic only when serial change was combined with the symptoms and ECG.

Later coronary evaluation identifies an obstructive coronary lesion judged responsible for the event. That result confirms the branch chosen earlier, but it does not retroactively make every similar symptom coronary disease. A different patient using the same words could follow another pathway if the ECG, serial troponin pattern, examination, and risk context differed. The words are not the diagnosis.

Management plan#

Immediate actions#

At urgent care, priorities are emergency transport, repeat vital assessment, and cardiac monitoring when available. They also include a clear handoff and avoidance of delay for low-value testing. Antiplatelet therapy may be appropriate in suspected acute coronary syndrome after checking allergy, active bleeding, and features that would raise concern for acute aortic syndrome. Exact treatment follows emergency protocols and is omitted here because dosing and contraindications require patient-specific review.

At the receiving hospital, the team treats the patient through an acute coronary syndrome pathway, consults cardiology, evaluates bleeding and kidney risk, and chooses antithrombotic and invasive strategies based on the confirmed syndrome and current guideline. Oxygen is not a routine treatment for a patient with normal saturation. Symptom relief must not replace disease-directed evaluation.

Alternative branches#

• If ST elevation or instability appears: Activate the time-critical reperfusion and resuscitation pathway immediately.
• If serial troponin remains low and stable, ECGs are nonischemic, and a validated pathway classifies the patient as low risk: Discharge may be reasonable only with clear follow-up and return instructions under that pathway.
• If the patient remains intermediate risk: Continue observation and select further testing through shared decision-making, prior-test history, local capability, and patient factors.
• If aortic, pulmonary, gastrointestinal, or other disease becomes more plausible: Redirect imaging and consultation rather than forcing every result into an ischemia narrative.

Medication-safety review includes antiplatelet or anticoagulant use, bleeding history, and kidney and liver function. It includes drug interactions and medicines that must be reconciled at discharge. No treatment decision rests on the case analysis alone.

Escalation, referral, and safety net#

This presentation requires emergency transfer at the first site because the condition is time-sensitive and the clinic cannot complete serial evaluation. Escalation becomes immediate for recurrent or severe discomfort, ST elevation, or new arrhythmia. It becomes immediate for fainting, hypotension, hypoxemia, or pulmonary edema. It becomes immediate for new neurologic findings, pulse asymmetry, or a sudden maximal pain pattern.

After hospital care, emergency instructions should be concrete. New pressure, burning, breathlessness, sweating, nausea, fainting, or discomfort in the arm, shoulder, jaw, back, or upper abdomen should prompt emergency services rather than driving or waiting for an office reply. The instruction must be available in the patient's preferred language and confirmed with teach-back.

Communication, shared decisions, and equity#

The clinician begins with a professional medical interpreter rather than asking a family member to translate high-stakes details. A useful explanation is: "Your symptoms can come from the stomach, but the pattern can also happen when the heart is not receiving enough blood. We cannot safely separate those causes here because the answer depends on repeat heart tracings and blood tests over time."

The team avoids describing the symptoms as atypical in a way that means unimportant. Sex, age, race, language, disability, and the patient's own label of indigestion can all distort triage, including yours, if they replace the actual symptom pattern. The same structured questions and escalation thresholds should be applied consistently.

Shared decision-making has a role once immediate threats are addressed, especially for intermediate-risk testing and long-term prevention. It does not turn an incomplete urgent-care evaluation into a preference-sensitive discharge choice. Transportation, caregiving, and cost are part of a safe plan, not social details added after the medical decision. So are health literacy and access to follow-up.

Follow-up and contingencies#

After an acute coronary syndrome, follow-up should reconcile medicines, confirm tolerance and adherence, address blood pressure, lipids, tobacco abstinence, activity, and other modifiable risks, and connect the patient with cardiac rehabilitation. The 2025 guideline identifies secondary prevention and cardiac rehabilitation as central after discharge. Follow-up timing depends on the hospital plan and clinical stability. The clinician also checks whether the patient understood which symptoms require emergency action and whether language, transportation, cost, or pharmacy access could interrupt the plan. If later evaluation contradicts the initial diagnosis, the problem list and patient explanation should be corrected rather than allowing a provisional label to become permanent.

Reasoning traps and alternative pathways#

• Anchoring on indigestion: A patient's chosen word describes a sensation, not its cause.
• Treating one normal result as timeless: An early troponin is interpreted within symptom timing and a serial pathway.
• Calling a nondiagnostic ECG normal: Absence of ST elevation does not exclude acute coronary syndrome. Serial tracings can reveal evolution.
• Letting tenderness end the workup: Reproducible tenderness can coexist with ischemia and must be weighed against the full pattern.
• Using a risk score as permission: Scores and pathways support decisions only in the populations, assays, and settings for which they were validated. Clinical instability overrides arithmetic.
• Testing every dangerous alternative at once: A focused differential uses discriminating history and examination to choose additional testing without delaying the highest-priority pathway.
• Assuming symptom relief proves a benign cause: Symptoms may fluctuate in acute coronary syndrome.
• Ignoring the transfer environment: A sound diagnosis plan can still fail through private transport, missing ECG copies, an unclear handoff, or lack of language support.

An alternative pathway remains plausible throughout. If serial troponin values were stable, ECGs nonischemic, and upper gastrointestinal symptoms clearly predominated after a validated cardiac evaluation, reflux or other gastrointestinal disease could move upward. If abrupt back pain, pulse difference, or a neurologic finding appeared, acute aortic syndrome would become the organizing concern. The discipline is to update, not defend the first impression.

Evidence limits and what could change#

Rapid high-sensitivity troponin pathways are assay-specific, and institutions differ in timing, reporting, imaging access, and observation capability. The evidence supports structured pathways, but it does not make every patient interchangeable. Pregnancy, advanced kidney disease, or persistent symptoms can change interpretation. So can prior coronary disease, very early presentation, or an alternative source of myocardial injury.

The 2021 chest pain guideline addresses evaluation, the 2022 ACC pathway details emergency disposition with high-sensitivity troponin, and the 2025 acute coronary syndrome guideline addresses management once the syndrome is established. None is a substitute for local protocols or bedside assessment. The outcome described in this analysis is one plausible branch, not a prediction for you if your own symptoms sound similar.

Key points#

• Acute coronary syndrome can present as pressure, burning, upper-abdominal discomfort, breathlessness, nausea, sweating, fatigue, or pain outside the chest.
• The urgent-care decision is whether the patient can be safely evaluated there, not whether the clinic can prove myocardial infarction before transfer.
• A first troponin below the reference limit can be followed by a diagnostic rise; symptom timing and serial change matter.
• ECG, troponin, history, examination, and trajectory are interpreted together through a validated pathway.
• A language-concordant handoff, monitored transport, and explicit return instructions are clinical safety interventions.